Back to trial details

Intake questionnaire

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

Applying to Vanderbilt-Ingram Cancer Center · Nashville, Tennessee

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Do you identify as female?
3. Have you been diagnosed with HR+/HER2-negative Breast Cancer?
4. Are you able to travel to Nashville for study visits?